no results
Ihre Produkte genau hier!
Ihre Suche lieferte keine Ergebnisse, aber Sie können sich mit Ihren Produkten und Leistungen auf dieser Seite präsentieren
Mit einem Eintrag auf Weltzentrum der Medizintechnik platzieren Sie Ihre Produkte und Dienstleistungen bei Google & Co. ganz weit oben und erreichen so jeden Tag mehrere Tausend potentielle Kunden aus der Medizintechnikbranche. Mehr Informationen gibt es auf der Firma eintragen - Seite.
no results
Ihr Unternehmen genau hier!
Ihre Suche lieferte keine Ergebnisse, aber Sie können sich auf dieser Seite präsentieren
Mit einem Eintrag auf Weltzentrum der Medizintechnik platzieren Sie Ihr Unternehmen bei Google & Co. ganz weit oben und erreichen so jeden Tag mehrere Tausend potentielle Kunden aus der Medizintechnikbranche. Mehr Informationen gibt es auf der Firma eintragen - Seite.
Preclinical imaging systems
Small animal studies require a variety of Preclinical imaging methods to examine molecular features, anatomical structure, and function. These modalities complement one another and provide the investigator with the most detailed information possible. Advances in technology are also creating new applications for such technologies. ANSTO Biosciences and Kawasaki Medical University are leading players in the market. Both companies offer multimodality imaging and use both traditional and non-traditional techniques.
As the demand for Preclinical imaging methods increases, government initiatives are encouraging research in the region. The Canadian government's R&D tax credit program is a prime example of this. With this support, the Preclinical imaging market is expected to grow at a rapid rate. Although there are a variety of pitfalls to be aware of, North America is projected to retain its leadership position in the near future. Here are some factors that are driving the growth of the Preclinical imaging market:
The largest market for Preclinical imaging systems is located in North America. The region is characterized by a strong research infrastructure, more skilled professionals, and higher acceptance of advanced technical devices. The region has numerous research projects and government policies that encourage the development of the industry. Various government initiatives and policies are helping companies boost their research and development work. These government policies are also helpful in fostering the growth of the industry. In addition to these benefits, the growth in the sector is primarily driven by the growth of pharmaceutical companies.
Bruker has recently introduced two new preclinical imaging systems. The SkyScan 1276 microCT, an X-ray micro-Computer Tomography, has combined the highest resolution and accessibility with other innovations. This device is designed to scan both small laboratory animals and in vitro biological samples. Its versatility and cost-effectiveness make it an ideal choice for drug discovery. With this technology, researchers can monitor the development of cancer drugs through better understanding of how they develop.
In 2015, the global market for preclinical imaging systems was valued at USD 1.8 billion. The high price of the devices and the underdeveloped infrastructure made it difficult for third-world countries to access these systems. However, the growth of the market is due to the rising adoption of in-vivo imaging systems for Preclinical research. These systems can identify the growth and efficiency of drug trials and help researchers optimize treatments and monitor their outcomes.
The main challenge for the Preclinical imaging market is that standalone systems are limited in terms of their technological and procedural capabilities. The company has therefore developed a new microCT that enhances the speed and resolution of the images. The system can also be used for in vitro experiments. For larger scale tests, the company has introduced the SkyScan 1576 system. Its SkyScan 1276 has a large number of features and is easy to handle.